Skip to content
Home/Companies/HealthTech/OncoVerse
OncoVerse

OncoVerse

HealthTech·US·Exited 2017·Held 1yr
Entry
2016
Hold
1yr
Exit
2017

Who owns OncoVerse?

OncoVerse was owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage) from 2016 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-17

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorHealthTech
StatusAcquired
Websitewww.oncoverse.de
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
AMR Bio
AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track OncoVerse

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy OncoVerse?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on OncoVerse.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue